임팩트 바이오메디컬(IBO)는 AMEX에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.46 (+4.39%), 시가총액 $0.06B, 52주 범위 $0.36 ~ $1.61.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances con
임팩트 바이오메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
임팩트 바이오메디컬의 현재 주가는 $0.46 (+4.39%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
임팩트 바이오메디컬의 시가총액은 약 $0.06B입니다.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicro